Utah Admin. Code R315-266-509 - Hazardous Waste Pharmaceuticals - Shipping Potentially Creditable Hazardous Waste Pharmaceuticals from a Healthcare Facility or a Reverse Distributor to a Reverse Distributor
(a)
Shipping potentially creditable hazardous waste pharmaceuticals. A healthcare
facility or a reverse distributor who transports or offers for transport
potentially creditable hazardous waste pharmaceuticals off-site to a reverse
distributor shall comply with applicable U.S. Department of Transportation
regulations in 49 CFR part 171 through 180 for any potentially creditable
hazardous waste pharmaceutical that meets the definition of hazardous material
in
49 CFR
171.8. For purposes of the Department of
Transportation regulations, a material is considered a hazardous waste if it is
subject to the Hazardous Waste Manifest Requirements of the U.S. Environmental
Protection Agency specified in Rule R315-262. Because a potentially creditable
hazardous waste pharmaceutical does not require a manifest, it is not
considered hazardous waste under the Department of Transportation
regulations.
(b) Delivery
confirmation. Upon receipt of each shipment of potentially creditable hazardous
waste pharmaceuticals, the receiving reverse distributor shall provide
confirmation, paper or electronic, to the healthcare facility or reverse
distributor that initiated the shipment that the shipment of potentially
creditable hazardous waste pharmaceuticals has arrived at its destination and
is under the custody and control of the reverse distributor.
(c) Procedures for if delivery confirmation
is not received within 35 days. If a healthcare facility or reverse distributor
initiates a shipment of potentially creditable hazardous waste pharmaceuticals
to a reverse distributor and does not receive delivery confirmation within 35
calendar days from the date that the shipment of potentially creditable
hazardous waste pharmaceuticals was sent, the healthcare facility or reverse
distributor that initiated the shipment shall contact the carrier and the
intended recipient, in other word the reverse distributor, promptly to report
that the delivery confirmation was not received and to determine the status of
the potentially creditable hazardous waste pharmaceuticals.
(d) Exporting potentially creditable
hazardous waste pharmaceuticals. A healthcare facility or reverse distributor
that sends potentially creditable hazardous waste pharmaceuticals to a foreign
destination shall comply with the applicable sections of Sections
R315-262-80
through
R315-262-89,
except the manifesting requirement of Subsection
R315-262-83(c),
in addition to Subsections R315-266-509(a) through R315-266-509(c).
(e) Importing potentially creditable
hazardous waste pharmaceuticals. Any person that imports potentially creditable
hazardous waste pharmaceuticals into the United States is subject to
Subsections R315-266-509(a) through R315-266-509(c) in lieu of Sections
R315-262-80
through
R315-262-89.
Immediately after the potentially creditable hazardous waste pharmaceuticals
enter the United States, they are subject to the applicable requirements of
Sections R315-266-500 through R315-266-510.
Notes
State regulations are updated quarterly; we currently have two versions available. Below is a comparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare.
No prior version found.